New York State Common Retirement Fund’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-42,600
| Closed | -$1.47M | – | 3301 |
|
|
2020
Q3 | $1.47M | Sell |
42,600
-327,243
| -88% | -$6.97M | ﹤0.01% | 1724 |
|
|
2020
Q2 | $6.18M | Buy |
369,843
+5,700
| +2% | +$96.8K | 0.01% | 1077 |
|
|
2020
Q1 | $5.25M | Sell |
364,143
-23,895
| -6% | -$611K | 0.01% | 1040 |
|
|
2019
Q4 | $13M | Buy |
388,038
+115,066
| +42% | +$3.22M | 0.02% | 850 |
|
|
2019
Q3 | $5.72M | Buy |
272,972
+225,372
| +473% | +$4.6M | 0.01% | 1177 |
|
|
2019
Q2 | $991K | Buy |
47,600
+5,100
| +12% | +$105K | ﹤0.01% | 2024 |
|
|
2019
Q1 | $950K | Hold |
42,500
| – | – | ﹤0.01% | 1987 |
|
|
2018
Q4 | $1.02M | Sell |
42,500
-5,700
| -12% | -$147K | ﹤0.01% | 1903 |
|
|
2018
Q3 | $1.31M | Hold |
48,200
| – | – | ﹤0.01% | 1928 |
|
|
2018
Q2 | $1.3M | Buy |
48,200
+9,100
| +23% | +$279K | ﹤0.01% | 1949 |
|
|
2018
Q1 | $1.25M | Sell |
39,100
-51,923
| -57% | -$1.83M | ﹤0.01% | 1889 |
|
|
2017
Q4 | $3.44M | Buy |
91,023
+53,423
| +142% | +$1.72M | ﹤0.01% | 1379 |
|
|
2017
Q3 | $932K | Hold |
37,600
| – | – | ﹤0.01% | 2039 |
|
|
2017
Q2 | $773K | Buy |
37,600
+10,699
| +40% | +$204K | ﹤0.01% | 2189 |
|
|
2017
Q1 | $585K | Buy |
26,901
+1
| +0% | +$21 | ﹤0.01% | 2316 |
|
|
2016
Q4 | $550K | Hold |
26,900
| – | – | ﹤0.01% | 2334 |
|
|
2016
Q3 | $404K | Hold |
26,900
| – | – | ﹤0.01% | 2420 |
|
|
2016
Q2 | $291K | Buy |
26,900
+16,200
| +151% | +$220K | ﹤0.01% | 2540 |
|
|
2016
Q1 | $145K | Hold |
10,700
| – | – | ﹤0.01% | 2810 |
|
|
2015
Q4 | $197K | Buy |
+10,700
| New | +$198K | ﹤0.01% | 2781 |
|
New York State Common Retirement Fund's AIMT Position: Q4 2020 in Review
New York State Common Retirement Fund sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 42,600 shares — an estimated $1.47M sold.
New York State Common Retirement Fund first reported a position in AIMT in Q4 2015 and held it in 20 quarters. The position peaked at $13M in Q4 2019. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.
- New York State Common Retirement Fund reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
- New York State Common Retirement Fund sold 42,600 Aimmune Therapeutics shares in Q4 2020, an estimated $1.47M.
- New York State Common Retirement Fund first reported a position in Aimmune Therapeutics in Q4 2015 and held it in 20 quarters.
- New York State Common Retirement Fund's Aimmune Therapeutics position peaked at $13M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.
Based on New York State Common Retirement Fund's 13F filing for Q4 2020, filed 8 Feb 2021.